Latest News

Latest News

News from the World Hepatitis Alliance

Supporting the development of national action plans in South America

31 Jan 2015 Bridie Taylor

Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...

Exploring new treatment developments and innovative ways to finance healthcare

31 Jan 2015 Bridie Taylor

New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...


News from infohep

Immunotherapy combination improves liver cancer survival

27 Nov 2019 Liz Highleyman
A combination of nivolumab (Opdivo) and ipilimumab (Yervoy), two different types of checkpoint inhibitor immunotherapy, led to higher response rates...

New NASH therapies show promise in mid-stage studies

26 Nov 2019 Liz Highleyman
Phase II study results presented at the AASLD Liver Meeting this month in Boston show that a number of experimental therapies improve markers of...

People with fatty liver disease struggle to lose weight

25 Nov 2019 Liz Highleyman
Losing weight may be especially difficult for people with fatty liver disease due to differences in their metabolism. But nonetheless, some can...

Sustained response to HCV antivirals boosts liver cancer survival

19 Nov 2019 Liz Highleyman
People with liver cancer who achieved a sustained virological response (SVR) to direct-acting antiviral (DAA) therapy for hepatitis C saw a reduction...

Hepatitis B antiviral drugs reduce liver cancer risk

19 Nov 2019 Liz Highleyman
Treating hepatitis B virus (HBV) with nucleoside/nucleotide antiviral drugs was associated with a lower risk of developing hepatocellular carcinoma (...

Hepatitis C incidence is low among Canadian men on PrEP

18 Nov 2019 Liz Highleyman
New cases of hepatitis C virus (HCV) infection among Canadian gay and bisexual men taking pre-exposure prophylaxis (PrEP) were uncommon compared...

Pre- and post-transplant antiviral treatment prevents hepatitis C transmission in all organ recipients, Canadian study finds

14 Nov 2019 Keith Alcorn
Adding a cholesterol-lowering drug to direct-acting antivirals (DAAs) prevented hepatitis C infection in all recipients of organ transplants from...

Coalition of liver associations calls for simplifying hepatitis C care

13 Nov 2019 Liz Highleyman
Leaders of liver disease associations from Europe, the United States, Latin America and Asia issued a global call to action at the AASLD Liver...

Therapeutic hepatitis B vaccine may lead to functional cure

13 Nov 2019 Liz Highleyman
An experimental therapeutic vaccine called NASVAC, which targets two different hepatitis B virus (HBV) antigens, led to a reduction in hepatitis B...

Emricasan and selonsertib fail to improve fibrosis in people with NASH

12 Nov 2019 Liz Highleyman
A pair of experimental therapies for non-alcoholic steatohepatitis (NASH) failed to offer notable improvements in controlled clinical trials, despite...